Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Discontinuation of rheumatoid arthritis (RA) treatment for lack or loss of initial response, tolerability issues, or development of antibodies against the therapeutic agent remains a challenge in clinical practice. |